An observational study in Acute Respiratory Failure, Mechanical Ventilation and Life-Supporting Treatments, sponsored by University of Wisconsin, Madison. Enrolling by invitation at 5 sites in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-05.
Sponsored by University of Wisconsin, Madison · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 16 studies in Communication by University of Wisconsin, Madison — 6 open to participants now, 7 under way, none of them phase 3. Communication · University of Wisconsin, Madison.
Among the 16 studies in Communication by University of Wisconsin, Madison, this one is one of 3 that started in 2024, is one of 4 observational ones, and was the 11th registered.
720 studies on the registry are indexed under Communication; 160 are open to participants now.
Browse Communication studies →6 of the 16 studies in Communication by University of Wisconsin, Madison are open now, in 1 country. Recruiting first, the newest first:
University of Wisconsin, Madison · Sites in United States
Ages 18+
University of Wisconsin, Madison · Sites in United States
Ages 18+ · Healthy volunteers
University of Wisconsin, Madison · Sites in United States
Ages 18+
University of Wisconsin, Madison · Sites in United States
Ages 45–89 · Healthy volunteers
University of Wisconsin, Madison · Sites in United States
Ages 18+ · Healthy volunteers
By country, each count listing its studies:
Of the 88 Communication studies recruiting now, 53 (60%) set no upper age limit and 28 (32%) stop at 75 or younger; 32 take children under 18; 34 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
16 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 3 started in 2024.
This study's planned enrollment of 7,818 is above the median of 104 across 132 observational studies indexed under Communication.
Median enrollment 291 across the 12 interventional studies, 420 across the 4 observational. Of the 9 that completed or were terminated, 4 (44%) have results posted.
This tab as a report to print or save as PDF → With an account.
University of Wisconsin, Madison is the lead sponsor of 1,190 studies on the registry; 181 are open to participants now.
Of its 157 completed or terminated interventional studies of FDA-regulated products, 118 (75%) have results posted.
2 of the studies in Communication by University of Wisconsin, Madison that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06985953University of Wisconsin, MadisonEvaluating the Communication Between Patients and Providers in Cancer Clinics | 2027-02 |
| NCT06654310University of Wisconsin, MadisonThe Fundamentals of Communication in Surgery | 2027-05-01 |
Add all 2 to your calendar (.ics) → With an account.
Among the 16 studies in Communication by University of Wisconsin, Madison, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to investigate a specific approach to patient care called a time-limited trial (TLT). This approach is sometimes used for people who develop critical illness and are cared for in an intensive care unit (ICU). A time-limited trial is a plan made together by medical teams, patients with critical illness (if they can take part), and their families or other important people helping to make their healthcare decisions. A time-limited trial starts with a discussion of the patient's goals and wishes. Then, a plan is made to use ICU treatments for a set period of time to give the patient the chance to recover. After this time, the patient's response to treatment will be reviewed to help guide what to do next.
Medical teams consider this kind of plan when it is not clear if a patient can recover to a quality of life that is acceptable to them. With a time-limited trial, patients, families, and medical teams experience this uncertainty together.
The main goal of this study is to find the best way to use TLTs for patients in the ICU who have trouble breathing and need mechanical ventilation to help them breathe. The hypothesis is that optimal time-limited trial delivery will reduce the time patients with acute respiratory failure spend in the ICU and will improve the intensive care unit experiences for their families and clinicians.
This is a multi-site observational study that will investigate the time-limited trial approach to care for patients with critical illness, which is a trial of life support with milestones and a timeline to help evaluate whether the patient is improving. The primary objective of this study is to define the optimal care delivery processes of a time-limited trial for adult intensive care unit (ICU) patients who develop acute respiratory failure requiring mechanical ventilation. The two aims of this study are to:
Aim 1: Map the current processes of time-limited trial care delivery for patients with acute respiratory failure.
Aim 2: Elucidate the relationships between time-limited trials, their care delivery processes, and end-of-life outcomes for patients, surrogates, and ICU teams.
For Aim 1, a focused ethnography of approximately 50 time-limited trials will be done to characterize how trials are currently being done in the intensive care unit. This will include direct observation of ICU care provided to patients and real-time interviews with their surrogates and the ICU team members providing their care. Qualitative analyses will be used to characterize TLT activities and team member roles. This data will support the construction of a systems engineering process map, which is a visual tool that diagrams the sequence of process steps and serves as a time-limited trial process measure.
For Aim 2, a prospective cohort of 5,810 patients with acute respiratory failure will be followed to evaluate relationships between time-limited trial exposure and ICU outcomes through a chart review and electronic health record (EHR) data abstraction. The extent to which trial care processes influence surrogate and ICU team member outcomes will be investigated by conducting surveys. Additionally, semi-structured interviews will be conducted with surrogates and ICU team members to investigate how time-limited trial processes work.
The hypothesis is that optimal time-limited trial delivery will reduce intensive care unit length of stay for patients with acute respiratory failure and improve the intensive care unit experiences for their families and clinicians.
Participants will be selected from patients who are admitted to an intensive care unit (ICU) at the University of Wisconsin Hospital, UnityPoint Health - Meriter Hospital, Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, or Northwestern Memorial Hospital. Surrogate participants will be the primary surrogate/s for an eligible patient, and ICU Team Member participants will be members of the hospital staff providing care for an eligible patient.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Participants
Acute respiratory failure:
Surrogates
The main person/s (primary surrogate/s, also known as legally authorized representative/s) who are making medical decisions on behalf of an eligible patient
ICU Team Members
A member of the interprofessional hospital staff that is caring for an eligible patient
Exclusion Criteria:
Participants
Surrogates
ICU Team Members
Participants will be selected from patients who are admitted to an intensive care unit (ICU) at the University of Wisconsin Hospital, UnityPoint Health - Meriter Hospital, Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, or Northwestern Memorial Hospital.
Surrogate participants will be the primary surrogate/s for an eligible patient.
ICU Team Member participants will be members of the hospital staff providing care for an eligible patient.
Intensive Care Unit (ICU) length of stay
Cumulative number of days that participant stays in the intensive care unit.
Time frame: Through participant study completion, an average of 8 days
Surrogate end-of-life intensive care unit (ICU) experience
Surrogate end-of-life intensive care unit (ICU) experience will be measured using the Family Satisfaction in the Intensive Care Unit (FS-ICU) questionnaire. The FS-ICU is a 24 item questionnaire that evaluates family members' satisfaction with their intensive care unit experience. Each question is scored on a 5-point scale from 1 (worst) to 5 (best). The total scores are then converted to a scale from 0 to 100, where 0 is the least satisfied and 100 is the most satisfied.
Time frame: Between 4 and 16 weeks after participant's hospital discharge
Intensive Care Unit (ICU) team acute moral distress
Intensive Care Unit (ICU) team acute moral distress will be measured using the Moral Distress Thermometer (MDT). The MDT first presents a definition of moral distress, then asks the respondent to rate their distress related to a specific context on a 10-point scale from 0 (none) to 10 (worst possible) moral distress.
Time frame: Up to 14 days after participant's hospital discharge
Direct observation of intensive care unit (ICU) care
Direct observations will include observations of interactions that are pertinent to time-limited trials (e.g., daily interprofessional rounds, nursing shift-change handoffs) and family meetings, including both formal (e.g., in a private conference room) or informal (e.g., on medical rounds or at the bedside) discussions between members of the ICU team, surrogates, patients (if able), and other family members. Observations will be documented using field notes, and family meetings will be audio-recorded and transcribed verbatim. Qualitative analysis of field notes and written transcripts will be done to look for themes and trends that emerge from the data.
Time frame: Through participant study completion, an average of 8 days
In-hospital mortality
A participant death occurring during the hospital stay.
Time frame: Through participant study completion, an average of 8 days
Length of mechanical ventilation
Cumulative number of days that participant receives invasive mechanical ventilation.
Time frame: Through participant study completion, an average of 8 days
Surrogate anxiety and depression
Surrogate anxiety and depression will be measured using the Hospital Anxiety and Depression Scale (HADS), a self-rated scale that aims to measure symptoms of anxiety and depression. The HADS has 14 total items, 7 items measuring anxiety and 7 items measuring depression. Each item is scored on a 4-point Likert scale where scores range from 0 (less anxious or depressed) to 3 (more anxious or depressed).
Time frame: Between 4 and 16 weeks after participant's hospital discharge
Patient and family centeredness of care
Patient and family centeredness of care will be measured using the Modified Patient Perceived Patient-Centeredness of Care (PPPC) Scale. The PPPC has 12 total items with a score range of 0 - 100, with higher scores indicating greater patient-centered care.
Time frame: Between 4 and 16 weeks after participant's hospital discharge
Surrogate Heard and Understood Measure
The Heard and Understood Measure evaluates the degree to which the surrogate felt heard and understood. This measure has one item with 5 categorical response choices which range from feeling not at all to completely heard and understood by the doctors, nurses and staff in the ICU. Results are summarized by participant counts for each choice.
Time frame: Between 4 and 16 weeks after participant's hospital discharge
Surrogate decisional regret
Surrogate decisional regret will be measured using the Decision Regret Scale (DRS) that measures distress or remorse after a health care decision. The DRS has 5 total items scored on a 5-point Likert scale where scores range from 1 (strongly agree) to 4 (strongly disagree). A higher score indicates more regret.
Time frame: Between 4 and 16 weeks after participant's hospital discharge
Real-time semi-structured qualitative interviews (Surrogate experience)
Serial, real-time interviews will be conducted following an interview guide that will be iteratively revised as necessary during data collection, according to methodological standards of qualitative interview research. The interviews will be audio-recorded and transcribed verbatim.
Time frame: Between participant ICU admission and ICU discharge, an average of 8 days
Semi-structured qualitative interviews (Surrogate experience)
Interviews will be conducted following an interview guide that will be iteratively revised as necessary during data collection, according to methodological standards of qualitative interview research. Surrogate interviews will also use an adapted form of chart-stimulated recall, a case-based interviewing method using prompts to help participants remember and reflect on past events. The interviews will be audio-recorded and transcribed verbatim.
Time frame: Between 4 and 16 weeks after participant's hospital discharge
Structured qualitative interviews (ICU team members experience)
Brief, real-time structured interviews will collect team members' knowledge, understanding, and approval of time-limited trials for patients in their care.
Time frame: Between participant ICU admission and ICU discharge, an average of 8 days
Semi-structured qualitative interviews (ICU team members experience)
Semi-structured interviews will be conducted following an interview guide that will be iteratively revised as necessary during data collection, according to methodological standards of qualitative interview research. Interviews will also use an adapted form of chart-stimulated recall, a case-based interviewing method using prompts to help participants remember and reflect on past events. The interviews will be audio-recorded and transcribed verbatim.
Time frame: Up to 4 weeks after participant's hospital discharge
Plan to share: No
Started Jan 2024 (actual). Primary completion is estimated for Mar 2028, 50 months after the start.
Of 51 non-industry observational studies under Communication, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 61. This study's planned 50 months is above that.
Counting every sponsor, half of 53 studies reached it within 25 months; a quarter within 9 and three quarters within 61.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Wisconsin, Madison →